Genetic counselors and congenital heart disease: Clinical roles, genetic testing practices, and perceived genetic testing utility
Journal of Genetic Counseling · 2024
DOI: 10.1002/jgc4.1821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Genetic Counseling, 2024. Verfasst von Sara M Fitzgerald-Butt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Genetic Testing, Genetic Counseling. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Genetic counseling and genetic testing are essential for individuals with congenital heart disease/defects (CHD/CHDs). However, the clinical practices of genetic counselors (GCs) and their preferences for different CHD genetic testing strategies are previously unexplored. To address these gaps, GCs ( n = 112) representing diverse specialties completed an online survey regarding their counseling and testing practices for syndromic CHD and apparently isolated/non‐syndromic CHDs (iCHD). We found practice variability around family screening recommendations, with prenatal respondents reporting lower prevalence of this practice for iCHDs ( p = 0.0004). We found that all specialties considered chromosomal microarray (CMA) the most common prioritized genetic test for syndromic and iCHD, while more prenatal respondents considered FISH and karyotype useful for iCHDs compared to postnatal respondents ( p = 0.0002 and p = 0.002, respectively). Among postnatal respondents, a higher proportion considered exome/genome sequencing as useful compared to prenatal respondents ( p = 0.0159); specifically, postnatal respondents' preference for exome/genome sequencing for iCHDs was ~2.6‐fold higher than prenatal respondents. We estimated participants' assessment of utility for different genetic testing modalities for iCHDs and found that prenatal respondents assigned higher mean utility to FISH ( p = 0.0002), karyotype ( p = 0.0006), and CMA ( p < 0.0001). There were relatively moderate to decreased utility scores for gene panels and exome/genome sequencing for iCHDs compared to cytogenetic testing, across all specialties. Overall, these results provide insight into GC practices and use of various genetic testing strategies for syndromic CHDs and iCHDs. Findings may help inform and/or standardize clinical practices for CHD genetic testing, though additional studies are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Obstetrics & Gynecology, Division of Maternal Fetal Medicine, Indiana University Health, Indianapolis, Indiana, USA.
- Stanford Healthcare, Stanford Center for Inherited Cardiovascular Disease, Stanford, California, USA.
- Department of Epidemiology, Indiana University Fairbanks School of Public Health, Indianapolis, Indiana, USA.
ORCID-Profile: Sara M Fitzgerald-Butt, Hannah E Ison, Benjamin M Helm
Zitieren
APA
Fitzgerald-Butt, S. M., Schartman, A. F., Schmit, K., Ison, H. E., & Helm, B. M. (2024). Genetic counselors and congenital heart disease: Clinical roles, genetic testing practices, and perceived genetic testing utility. Journal of Genetic Counseling. https://doi.org/10.1002/jgc4.1821
Vancouver
Fitzgerald-Butt SM, Schartman AF, Schmit K, Ison HE, Helm BM. Genetic counselors and congenital heart disease: Clinical roles, genetic testing practices, and perceived genetic testing utility. Journal of Genetic Counseling. 2024. doi:10.1002/jgc4.1821
BibTeX
@article{FitzgeraldButt2024,
author = {Fitzgerald-Butt, Sara M and Schartman, Allison F and Schmit, Kelly and Ison, Hannah E and Helm, Benjamin M},
title = {Genetic counselors and congenital heart disease: Clinical roles, genetic testing practices, and perceived genetic testing utility},
journal = {Journal of Genetic Counseling},
year = {2024},
doi = {10.1002/jgc4.1821}
}
EUVIMED